Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholine Release at Cholinergic Neuromuscular Junctions (ACh Release at NMJ)
- Target
- ACh Release at NMJ
- Molecular classification
- Synaptic Transmission, Neurotransmitter Release, Presynaptic Target
01
Overview
Acetylcholine (ACh) release at cholinergic neuromuscular junctions is a critical step in translating motor neuron activity into skeletal muscle contraction. This process involves the calcium-dependent exocytosis of ACh-containing vesicles from the presynaptic terminal, diffusion across the synaptic cleft, and binding to nicotinic acetylcholine receptors on the muscle fiber. Precise control of ACh release and subsequent hydrolysis by acetylcholinesterase is essential for coordinated muscle movements. This target is modulated by various toxins and drugs, making it a key point of intervention for treating neuromuscular disorders.
- Other names
- Neuromuscular Junction Acetylcholine ReleaseCholinergic NMJ TransmissionACh Exocytosis at NMJMotor Neuron Acetylcholine Release
02
Mechanism of action
Modulation of presynaptic calcium channels, SNARE protein function, or vesicle fusion to either inhibit or enhance acetylcholine release into the synaptic cleft.
03
Biological functions
Neuromuscular TransmissionMuscle Contraction InitiationVoluntary Movement ControlAction Potential Propagation
04
Disease associations
Myasthenia Gravis (indirectly, via downstream effects)Lambert-Eaton Myasthenic SyndromeBotulismNeuromuscular Disorders
05
Safety considerations
Excessive muscle weakness or paralysisRespiratory failureAutonomic dysfunction (with drugs affecting ACh release)Drug interactions
06
Interacting drugs
Botulinum Toxin
6 more in the full profile.
Beyond the preview
Go deeper on Acetylcholine Release at Cholinergic Neuromuscular Junctions (ACh Release at NMJ).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acetylcholine Release at Cholinergic Neuromuscular Junctions (ACh Release at NMJ).